Germline variants and mosaic chromosomal alterations affect COVID-19 vaccine immunogenicity

Authors:

Abstract
No abstract available
Funding Information
  • Japan Prize Foundation
  • Moonshot Research and Development Program
  • Japan Society for the Promotion of Science (23K14451)
  • Japan Society for the Promotion of Science (22H00476)
  • RIKEN
  • Diabetes-Stiftung
  • Osaka University
  • Public Foundation of Vaccination Research Center
  • Japan Agency for Medical Research and Development (JP21fk0108469)
  • Japan Agency for Medical Research and Development (JP23fk0108686)
  • Japan Agency for Medical Research and Development (JP24tm0524008)
  • Japan Agency for Medical Research and Development (JP243fa627010)
  • Japan Agency for Medical Research and Development (JP24gm1810011)
  • Japan Agency for Medical Research and Development (JP24km0405217)
  • Japan Agency for Medical Research and Development (JP243fa627002)
  • Japan Agency for Medical Research and Development (JP24kk0305022)
  • Japan Agency for Medical Research and Development (JP24tm0524002)
  • Japan Agency for Medical Research and Development (JP24wm0625504)
  • Japan Agency for Medical Research and Development (JP243fa627011)
  • Japan Agency for Medical Research and Development (JP24ek0109594)
  • Japan Agency for Medical Research and Development (JP24ek0410113)
  • Japan Agency for Medical Research and Development (JP24zf0127008)
  • Takeda Science Foundation
  • Precursory Research for Embryonic Science and Technology (JPMJPR21R7)
  • Precursory Research for Embryonic Science and Technology (JPMJPR22R2)

This publication has 57 references indexed in Scilit: